Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rak piersi zapalny, niezależnie od typu (stadium IIID)
- •Rak piersi niezapalny typu triple-negative lub HER2+, stadium IIB do IIIA-C
- •Wystarczająco dobry stan zdrowia do chemioterapii przedoperacyjnej
✗ Disqualifies
- •Rak piersi zapalny stadium IV
- •Rak piersi typu luminal A lub luminal B
- •Rak piersi stadium I-IIA
- •Brak możliwości komunikacji w języku słoweńskim
- •Niemożność przestrzegania instrukcji badania
- •Zły stan zdrowia do chemioterapii
- •Planowana operacja jako pierwsze leczenie
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- February 18, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Institute of Oncology Ljubljana
Ljubljana, Slovenia
Trial contact
Klavdija Korošec
Neza Gros
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.